Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 3, Issue 3 , Pages 177-179, July 2007

Commentary on “Health economics and the value of therapy in Alzheimer’s disease.” Cholinesterase inhibitors in Alzheimer’s disease—Evidence-based or evidence-biased?

Psychopharmacology Research Program and Department of Psychiatry, Sunnybrook Health Sciences Center; and Departments of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1552-5260(07)00485-2

doi:10.1016/j.jalz.2007.04.389

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 3, Issue 3 , Pages 177-179, July 2007

Article Tools